Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all blood cells are produced. Plasma cells are a type of white blood cell that ...

New criteria make high-risk smoldering multiple myeloma treatable, opening door to future 'chronic' disease status ...

The 2025 Rocket Classic will see its field cut after Friday's second round. Follow the latest updates and see which PGA Tour stars could miss the cut.

Several PGA Tour players withdraw from the Rocket Classic just days before it begins, prompting notable changes to the field.

The EMA has extended the indications for Darzalex (daratumumab) to the treatment of adults at high risk of developing multiple myeloma.

Early intervention in high-risk smoldering myeloma with lenalidomide delays progression by up to 7 years and achieves sustained MRD negativity in one third of patients.

Multiple bedbug infestations in Las Vegas hotels have led to lawsuits as guests reported severe "injuries" and emotional distress. Attorney Brian Virag discussed the details.

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma The following represents disclosure information provided by ...

A multi-institutional study led by the Icahn School of Medicine at Mount Sinai reports one-third of patients with relapsed or refractory multiple myeloma remained in remission for at least five ...

J&J is literally borrowing from multiple myeloma to grow its lung cancer pipeline. The company has explored Talvey and Tecvayli in lung cancer, Bauml said.

--Johnson& Johnson announced today initial Phase 1 results of JNJ-79635322, a novel investigational trispecific antibody in patients with relapsed or refractory multiple myeloma. Findings were ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without detectable cancer for years after facing certain death.